Abstract: With the advent of antiretroviral therapy, remarkable progress has been made in the reduction of morbidity and mortality associated with the human immunodeficiency virus (HIV). As a result, in both the developed and developing world, reproductive decision-making and family planning has re-emerged as an important health issue among HIV-seroconcordant and -serodiscordant couples. This study sought to explore contraceptive attitudes and practices among HIV-seropositive and -serodiscordant couples in the US and Zambia and to compare contraceptive decision-making between seroconcordant and discordant couples. Study results suggest that while most participants expressed a willingness to use protection to prevent pregnancy, the majority were not using protection consistently. Similarly, among seropositive younger men in both the US and Zambia, more men expressed a desire to have children than women of either serostatus group. Study outcomes also suggest that male and female condom use to reduce HIV transmission within couples is limited. Thus, as males are largely the sexual decision makers regarding condom use, women's attitudes or plans regarding child bearing may be eclipsed by those of their male partners, and recent reductions in provision of female condoms in the developing world may further reduce women's options to protect themselves and prevent pregnancy. Education and counseling on vertical and horizontal transmission of HIV among both seropositive and serodiscordant couples should be an element of family planning efforts. Conversely, family planning should be a critical element of HIV counseling and testing strategies to realistically respond to the desires of both members of the couple.
Introduction
With the advent of antiretroviral therapy, remarkable progress has been made in the reduction of morbidity and mortality associated with the human immunodeficiency virus (HIV). As a result, in both the developed and developing world, reproductive-decision making and family planning has re-emerged as an important health consideration among HIV-seroconcordant and -serodiscordant couples. The rate of contraceptive use is lower in sub-Saharan Africa (22%) than developed regions of the world (62%) 1 and the need for modern contraceptive methods appears to exceed their actual use. 2 Modern contraceptive methods here refer to female and male sterilization, intrauterine devices (IUDs), hormonal methods (eg, oral pills, injections, hormone implants, skin patches, vaginal rings), condoms and vaginal barriers (eg, diaphragms, cervical caps and spermicides). Traditional contraceptive methods referring to abstinence, withdrawal, the rhythm methods and lactational amenorrhea. Zambia has a population of 12 million people, of whom an estimated 1.1 million are living with HIV. It has been particularly hard-hit by the HIV/acquired immune deficiency syndrome (AIDS) pandemic, with infection rates as high as 42% among pregnant women in Lusaka, the capital city (Brian Chituwo, Minister of Health, personal communication, 2008). Urban antenatal clinics in regions such as Livingstone have reported rates as high as 32.3%. 4 Nationwide, the HIV prevalence rate among pregnant women is 19.3% and it is estimated that approximately 95,000 children are currently HIV-positive. 5 More than 90% of these infections are the result of mother-to-child transmission (MTCT) of HIV. HIV is predicted to increase infant mortality to 82 per 1,000 live births. 6 A woman's identity may be embodied by her reproductive and childbearing ability, regardless of her HIV status, culture, or the potential health risks associated with HIV transmission, pregnancy, and giving birth. 7 In sub-Saharan Africa, a woman's 'purpose in life' includes her ability to bear children and many women report feeling pressured by their community and society to have children. 8, 9 Social pressure may not differentiate between those who are HIV seropositive and those who are seronegative. Among HIV-positive men and women in Kenya and Malawi, those who were married or cohabitating were more likely to be sexually active and to use condoms less than those who were not married or cohabitating. 10 Slightly less than half, 44%, of HIV-positive Kenyan women and 40% of HIV-positive Malawian women reported that their last pregnancy was unplanned or unwanted. Unwanted pregnancy rates in sub-Saharan Africa are estimated to be 20%-40%. 10, 11 A recent study found that only 21% of women with a sexual partner use modern contraceptive methods, and in another study, less than 25% of women reported using modern contraceptives. 10, 11 Of HIV-positive women in Kenya and Malawi who reported not ever wanting a child or not within the next 2 years, less than one-third and one-fifth, respectively, were using modern contraceptives. 10 In addition, health risks associated with pregnancy are high in sub-Saharan Africa. Among women who are HIV seronegative, an estimated one in every 22 women in sub-Saharan Africa has a lifetime risk of dying owing to complications during pregnancy. 12 Finally, HIV infection rates for women are higher than those for men in Zambia (54% of all infections are among women) and 85% of HIV infections in women occur in marital and cohabiting relationships. 4, 13 Thus, among those women wishing to produce children, health risks include those associated with pregnancy, birth, and both horizontal (between sexual partners) as well as vertical transmission (from mother to child), while contraception use appears to be modest.
A study of serodiscordant couples in Rwanda and Zambia found that, in both locations, knowledge of contraception was high, yet actual contraception use was low.
14 Although contraceptive use is higher for women in Zambia than Rwanda, women in both settings reported greater knowledge and use of contraceptive methods than men, leading the investigators to conclude that women may use contraceptives without their partners' involvement or knowledge.
14 Of women surveyed in Zambian prenatal clinics in 2004, only 19% reported they had ever had sex while using a male condom to protect against sexually transmitted diseases (STDs) and/or HIV. 4 Clearly, many seropositive men and women are prepared to risk HIV transmission and HIV re-infection rather than diminish their reproductive potential 8, 9, 15 and the acceptability and use of sexual barrier products are influenced by values related to bearing children.
Not unlike female populations in sub-Saharan Africa, of the estimated 146,692 adolescent and adult females living with HIV/AIDS in the 34 of the United States (US) reporting HIV infection rates, the vast majority are in their reproductive years. 16 In 2007, 68% of new HIV infections in the US were among women of childbearing age, with 81% of these being among minority women. 16 Estimates from the pre-highly active antiretroviral therapy (HAART) era (1988) (1989) (1990) (1991) (1992) (1993) (1994) suggested that 7,000 HIV-positive women would become pregnant each year. 17 With the advent of effective therapeutic interventions for HIV-positive mothers, the live birth rate is now 150% higher than in the pre-HAART era. 18 A review of factors influencing fertility desires and intentions among HIV-positive women in the US found that 30% of women in Ohio, 55% in Louisiana, and 40% from southern states (Georgia, and North and South Carolina) had been pregnant since their diagnosis. 19 These numbers may be related to a variety of factors, including an increase in prenatal screening, the spread of HIV infection through heterosexual contact, but most likely, the desire of women to bear children despite health concerns. 20, 21 In the US, reproductive decision-making among AfricanAmerican women living with HIV appeared to be influenced by misinformation associated with transmitting the virus to their children. 8 Other factors associated with decisionmaking included previous reproductive experience (eg, live births, abortions), social support, spiritual and religious beliefs and practices, as well as the woman's own health status. [22] [23] [24] [25] [26] [27] Among HIV-seropositive and -seronegative African-American women, self-esteem and self-efficacy were Family planning among HIV couples in the US and Zambia Dovepress submit your manuscript | www.dovepress.com Dovepress not as strongly predictive of the desire for children as was age, previous reproductive experience (ie, abortions), and religious beliefs. 28 Finally, many HIV-seropositive AfricanAmerican women plan to have children despite their own uncertainty regarding the potential of MTCT. 8 While older HIV-positive women expressed relief about not having to make the decision of planning a pregnancy while living with the virus, younger women reported that deciding to become pregnant, or resolving how to respond to an unplanned pregnancy, was not determined by their HIV status. 8, 24, 25, 27 Clearly, there is a need to minimize exposure to HIV and STDs while maximizing the potential to become pregnant, in contrast to the current practice of unrestricted unprotected sex when seeking to become pregnant. 29 Family planning and contraceptive use among people living with HIV worldwide is a growing priority in research. 30 Thus, information on the contraceptive methods and plans of couples living with HIV can inform strategies and interventions designed to reduce vertical and horizontal HIV transmission in this population. This study sought to explore contraceptive attitudes and practices among HIV-seropositive and -serodiscordant couples in the US and Zambia and to compare contraceptive decision-making between seroconcordant and discordant couples.
Material and methods

Participants and recruitment
This study presents data drawn from a larger ongoing study, the NOW2 Project (R01MH63630).
Prior to participant recruitment, research reviews and approvals were obtained in accordance with the provisions of the US Department of Health and Human Services, the University of Miami Miller School of Medicine (UMMSM) Institutional Review Board (IRB), and the University of Zambia Research Ethics Committee (REC). Participants were recruited between May 2005 and October 2009, were 18 years of age or older, and were sexually active HIV-serodiscordant and -seroconcordant heterosexual couples living in urban Miami, Florida, USA and Lusaka, Zambia. Participants were screened for eligibility, ie, currently sexually active, aged 18 years or older, in a couple relationship (relationship defined here as having existed a minimum of 6 months, to reduce potential attrition due to separation), and at least one member of the couple being HIV seropositive.
Participants at the Miami site (n = 223 couples) were recruited from clinic sites at the UMMSM/Jackson Memorial Hospital (JMH) and outlying community health clinics in Miami-Dade County. Lusaka site participants (n = 220 couples) were recruited from The University Teaching Hospital (UTH) Voluntary Counseling and Testing Family Support Unit (VCT-FSU) and additional participants were recruited from KARA Counseling Centre, the Network for Zambian People Positive (NZP+), and outlying Community Health Clinics in the Lusaka urban area.
Almost all of the individuals approached agreed to participate; approximately 5% declined. Approximately 27% of couples screened for enrollment in the US and Zambia did not meet the couple relationship criteria (they had no partner, were not in a relationship for more than 6 months, had undergone a recent break-up); an additional 5% were ineligible owing to lack of sexual activity within the previous month. In the US, all consents and assessments were conducted in English. In Zambia, all consents and assessments were conducted in English, or Nyanja or Bemba (primary local languages in Lusaka), and all Zambian study staff were fluent in all three languages.
Following provision of informed consent, both couple members completed a baseline assessment of sexual and demographic data using Audio Computer Assisted SelfInterview (ACASI). 31 Participants received monetary compensation for their time and travel expenses (US: $60 per assessment; Zambia: K50,000 per assessment). Participants were screened for STDs and HIV at enrollment via urine samples for gonorrhea and chlamydia and blood samples for syphilis and HIV, if HIV status was unknown. HIV-seropositive participants were required to provide verification of serostatus prior to enrollment. Participants were notified of their test results and referred for appropriate no-cost treatment for STDs prior to being enrolled in the study. Those participants newly identified as being HIV seropositive were referred for counseling and assessment for HAART. Owing to distress following an HIV diagnosis, participants testing newly HIV seropositive were not eligible to enroll for 2 weeks post-diagnosis.
Measures Demographics
This questionnaire included collection of data on age, ethnicity, educational level, employment status, HIV serostatus, approximate date of HIV diagnosis, mode of infection, marital status, current partner's and children's serostatus, family planning, and number of children.
Sexual activities questionnaire
This 55-item scale was adapted from the Sexual Risk Behavior Assessment Schedule (SERBAS). 32 Responses The SERBAS identifies frequency on a Likert-type scale as "all the time or 9 times out of 10 = 5, most of the time or 7 times out of 10 = 4, half of the time or 5 times out of 10 = 3, sometimes or 3 times out of 10 = 2, or never = 1." The SERBAS was used to assess consistency of male and female condom use.
Barrier methods questionnaire 
Sexual diary
Participants were asked to recount their sexual activities, indicating for each day of the week whether or not they had intercourse, and if so, the type of sexual barrier method used, if any. This diary used a pictorial representation of the five types of sexual barrier products that were introduced in the intervention.
Statistical analyses
Analyses were conducted with contraception use as the between-subjects factor and demographic variables and 
Results
Participant characteristics
Data from participants providing information for all data categories are summarized by country and serostatus in Tables 1 through 4. Seropositive US (n = 380) and Zambian (n = 409) participants and seronegative US (n = 64) and Zambian (n = 22) participants differed in age (seropositive Zambians were younger, F = 192.63, P  0.001), employment status (higher employment rates in Zambia among both seropositive (χ 2 = 92.88, P  0.001) and seronegative (χ 2 = 11.66, P = 0.009) participants), income (lower incomes in Zambian seropositive participants (χ 2 = 156.48, P  0.001)), and plans for additional pregnancies. Notably, more seropositive (χ 2 = 72.59, P  0.001) Zambians had plans to have more children than did seropositive participants in the US.
Among the US participants, more HIV-negative women than men had plans for children (χ 2 = 14.26, P = 0.001) though mean ages were similar within both the US and Zambian samples. When the data were separated by gender, US HIV-seropositive male participants were older (F = 11.57, P = 0.001), and HIV-seropositive women had lower incomes (χ 2 = 15.51, P = 0.004) than those US participants who were seronegative. Among Zambians, when data were separated by gender, seronegative and seropositive participants did not differ in employment status, income, education, or plans to have children. Contraceptive planning and use
Zambia
Less than half of seropositive participants (n = 94, 46%) reported using contraception all of the time and 34 participants (17%) never used any form of contraception in the month prior to study entry (see Tables 5 and 6 ). Of all seropositive participants, 17 (10%) reported using protection to prevent pregnancy, and 72 (43%) stated that they used protection to prevent STD transmission, while 72 (43%) stated they used protection for both purposes. However, the majority of seropositive participants stated that they would be very willing (307, 75%) to use protection to prevent pregnancy.
Of seronegative participants, 6 (67%) reported using contraception all of the time and 1 (11%) never used any form of contraception in the month prior to study entry. Of the seronegative participants, none endorsed using protection to prevent pregnancy, 4 (50%) stated that they used protection to prevent STD transmission, and 4 (50%) stated that they used protection for both purposes, though all of these participants had seropositive partners. However, the majority of seronegative participants stated that they would be very willing (16, 73%) to use protection to prevent pregnancy and 18 (82%) said they would be very willing to use protection to prevent pregnancy and STD transmission.
US
Similar to the results obtained in the Zambian sample, less than half of seropositive participants (n = 117, 48%) reported that they used contraception all of the time and 58 (23%) never used any form of contraception in the month prior to study entry (see Tables 7 and 8 ). Of the seropositive participants, 7 (4%) stated that they used protection to prevent pregnancy, 112 (60%) reported that they used protection to prevent STD transmission, and 55 (29%) stated that they used protection for both purposes. The majority of seropositive participants stated that they would be very willing (277, 73%) to use protection to prevent pregnancy.
In contrast to Zambian results, 44% of seronegative participants (n = 19) used contraception all of the time and Family planning among HIV couples in the US and Zambia Dovepress submit your manuscript | www.dovepress.com Dovepress 8 (19%) never used any form of contraception in the month prior to study entry. Similar to Zambia, of the seronegative participants, none endorsed using protection to prevent pregnancy, but more US participants, 22 (63%), stated that they used protection to prevent STD transmission and 11 (31%) stated that they used protection for both purposes. However, the majority of US seronegative participants stated that they would be very willing (42, 66%) to use protection to prevent pregnancy and 52 (81%) said they would be very willing to use protection to prevent pregnancy and STD transmission.
Age-related analyses
We compared plans for children by serostatus between the two samples, separating both samples by gender and age. Based on the anticipated fertility of the female samples, we divided those samples at 45 years of age and compared reproductive desires by age group and gender.
Zambia
Obtained percentages of male participants endorsing plans to have children differed between serostatus categories (positive, negative) though the majority of neither positive nor negative men (all of whom were in a relationship with a seropositive partner) planned to have more children. However, greater numbers of both younger (χ 2 = 49.96, P  0.001) and older (χ 2 = 7.36, P  0.001) seropositive men planned to have more children compared to seronegative men. Among younger female participants, more seropositive women planned to have additional children (χ 2 = 49.59, P  0.001). In contrast, older seropositive women expressed no desire to have more children (χ 2 = 6.4, P = 0.011).
US
Obtained percentages of male participants endorsing plans to have children differed between serostatus categories (positive, negative) though the majority of neither positive nor negative men (all of whom were in a relationship with a seropositive partner) planned to have more children. However, greater numbers of younger seropositive men than seronegative men planned to have more children (χ 2 = 7.12, P  0.001). There were no differences in the desire to have children between serostatus groups among 
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older men (χ 2 = 1.80, P  0.001). Among younger female participants of both serostatus groups, most women did not plan to have more children. However, there was no difference between serostatus groups (χ 2 = 0.47, P = 0.491). No women in the older age groups endorsed plans for having more children.
Discussion
This study explored attitudes and practices regarding contraception in HIV-seropositive and -serodiscordant couples the US and Zambia. Results from both sites suggest that, while most couples reported no plan to have more children and expressed a willingness to use protection to prevent pregnancy, the majority were not engaging in condom use consistently and many were not using any form of contraception at all. Similarly, among the Zambian and US seropositive younger age group, more men expressed a desire to have children than women of either serostatus group. Finally, more Zambians endorsed plans to have more children, regardless of serostatus.
Though the two country populations differed with regard to several demographic factors, frequency of condom use was remarkably similar. The majority of seronegative participants did not endorse consistent condom use, and less than half used some sort of protection consistently. In contrast, more than half of the seronegative Table 5 Contraceptive use and planning: HIV-positive men and women in Zambia Number of participants Number of seronegative partners n = 409 n = 22
How willing would you be to use a product that could protect against HIV reinfection or transmission?
Family planning among HIV couples in the US and Zambia Dovepress submit your manuscript | www.dovepress.com Dovepress participants used protection, but primarily for the purpose of prevention of transmission rather than prevention of pregnancy. Study outcomes suggest that condom use to reduce HIV transmission within couples is limited among seroconcordant couples, which may have been due to an assumed 'invulnerability' to infection. More importantly, the lack of differences observed among younger women of both countries and in both positive and negative serostatus groups suggests that reproductive desires held by women may not change following HIV infection. This suggests an important area for intervention to ensure prevention of MTCT, especially in the developing world where adherence to medications associated with prevention of MTCT has been variable. Similarly, in both locations, lifestyle interventions during pregnancy may be merited to address the special needs of women on HAART and of their children, to ensure optimal adherence and follow up during pregnancy and post-partum.
A desire for more children was expressed by more seropositive Zambian men than those Zambians, of either gender, who were seronegative. Thus, seronegative Zambian women, who may not desire children, may not be able to negotiate condom use to protect themselves from HIV infection owing to their partners' wishes for children. As men are the primary decision-makers regarding male condom use, women's attitudes or plans regarding childbearing may In the past month, during times when you had vaginal sex, how often did you or he use any form of protection?
Never in the past month: 1 (11.1%) Sometimes: 1 ( thus be eclipsed by their male partners' desires. Reductions in the provision of female condoms in Zambia may further reduce women's abilities to protect themselves and prevent pregnancy. Desires for more children may also be influenced by a lack of knowledge regarding MTCT and the potential for infection of the neonate during pregnancy. Future studies should examine the association between knowledge and behavior and should include men in the MTCT process, providing education to both members of the couple regarding reproductive plans and strategies for safer sex and safer pregnancy. This study may not be widely generalizable and it utilized a highly specific cohort in the US; the majority of US participants had extremely low incomes. Study limitations include a lack of dyadic analyses that might have provided additional information regarding the influence of couple members' attitudes on each other's attitudes and behaviors. Future studies should utilize more sophisticated dyadic analytic techniques addressing the influence of partner preferences as well as behavior on behavioral outcomes. This study highlights the similarity of reproductive plans among seronegative persons and those living with HIV in the US and Zambia. Clearly, efforts to reduce transmission that do not include attention to reproductive planning of both men and women may be of limited efficacy. Education and counseling on the vertical and horizontal transmission of HIV among both seropositive and serodiscordant couples should be an element of family planning efforts. Conversely, family planning should be a critical element of HIV counseling and testing strategies to realistically respond to the desires of both members of the couple.
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